Please login to the form below

Not currently logged in
Email:
Password:

Sanofi’s US pharma head joins Synta as CEO

Anne Whitaker also has experience at GSK
synta-anne-whitaker

Synta Pharmaceuticals has named the former head of Sanofi's pharma operations in the US and Canada as its new CEO.

Anne Whitaker served as president, North America pharmaceuticals, at Sanofi since September 2011 overseeing all pharma and consumer healthcare operations within the region. She also served as a member of Sanofi's global leadership team, global commercial operations committee and US regional management committee.

She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.

“Synta presents an exciting opportunity defined by a late stage product, ganetespib, that has shown promising activity in multiple indications and a pre-clinical programme, HDC, that has significant potential to generate new drug candidates,” said Whitaker.

Prior to joining Sanofi in 2011, Whitaker spent nearly two decades at GlaxoSmithKline (GSK), progressing through the ranks to eventually hold a senior VP role. She began her career at Delta Communications before joining the Upjohn Company in 1991 as a metabolic disease specialist.

14th August 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics